Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Mater Chem B ; 8(36): 8282-8293, 2020 09 23.
Artículo en Inglés | MEDLINE | ID: mdl-32785356

RESUMEN

Hemorrhage remains one of the direct causes of high mortality. The development of ideal hemostatic materials with sound ability to deal with severe wound is urgent needed. Although starch-based hemostatic powder has been widely used, hydrous physiological environments severely hamper its binding to the target tissue, thereby limiting the effectiveness in hemostasis. Herein, inspired by mussel adhesive protein, a novel injectable tissue-adhesive hydrogel (St-Dopa hydrogel) composed of starch, succinic anhydride and dopamine was developed in situ by enzymatic crosslinking. The results show that St-Dopa hydrogels were intimately integrated with biological tissue and formed robust barriers to reduce blood loss. St-Dopa hydrogels exhibited superior capacity for in vitro and in vivo hemostasis as compared with chitin hydrogels. In addition to the ease of operation, St-Dopa hydrogels exhibited rapid sol-gel transition, porous microscopic morphology, good swelling ratio and biodegradability, tissue-like elastomeric mechanical properties and excellent cyto/hemo-compatibility. These results suggest that this newly developed St-Dopa hydrogel is a promising biological adhesive and hemostatic material.


Asunto(s)
Hemorragia/tratamiento farmacológico , Hemostasis/efectos de los fármacos , Hemostáticos/uso terapéutico , Hidrogeles/uso terapéutico , Almidón/uso terapéutico , Adhesivos Tisulares/uso terapéutico , Animales , Línea Celular , Dopamina/análogos & derivados , Dopamina/uso terapéutico , Dopamina/toxicidad , Módulo de Elasticidad , Hemostáticos/síntesis química , Hemostáticos/toxicidad , Hidrogeles/síntesis química , Hidrogeles/toxicidad , Masculino , Ensayo de Materiales , Ratones , Porosidad , Conejos , Almidón/análogos & derivados , Almidón/toxicidad , Anhídridos Succínicos/química , Anhídridos Succínicos/uso terapéutico , Anhídridos Succínicos/toxicidad , Porcinos , Adhesivos Tisulares/síntesis química , Adhesivos Tisulares/toxicidad , Sustancias Viscoelásticas/síntesis química , Sustancias Viscoelásticas/uso terapéutico , Sustancias Viscoelásticas/toxicidad
2.
Nutr Cancer ; 68(6): 1052-63, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27367460

RESUMEN

Dietary fiber has been reported to prevent preneoplastic colon lesions. The aim of this study was to determine the effect of resistant starches, novel dietary fibers, on the development of colonic preneoplasia and Wnt signaling in azoxymethane (AOM)-treated rats and mice fed resistant starches at 55% of the diet after AOM treatment. Another objective was to determine the effect of resistant starches on the development of preneoplasia in rats treated with antibiotics (Ab), administered between AOM treatment and resistant starch feeding. Diets containing resistant starches, high-amylose (HA7), high-amylose-octenyl succinic anhydride (OS-HA7), or high-amylose-stearic acid (SA-HA7) were compared with control cornstarch (CS). The resistant starch content of the diets did not alter the yield of colonic lesions but animals treated with AOM and fed the diet with the highest resistant starch content, SA-HA7 developed the highest average aberrant crypt foci (ACF) per animal. Mice fed the OS-HA7 diet had decreased expression of some upstream Wnt genes in the colonic crypts. This study suggests that further research is needed to determine if resistant starch impacts colon carcinogenesis in rodents.


Asunto(s)
Anticarcinógenos/uso terapéutico , Neoplasias del Colon/prevención & control , Prebióticos , Lesiones Precancerosas/prevención & control , Almidón/uso terapéutico , Vía de Señalización Wnt , Focos de Criptas Aberrantes/metabolismo , Focos de Criptas Aberrantes/microbiología , Focos de Criptas Aberrantes/patología , Focos de Criptas Aberrantes/prevención & control , Animales , Antibacterianos/efectos adversos , Anticarcinógenos/metabolismo , Azoximetano/toxicidad , Carcinógenos/toxicidad , Colon/efectos de los fármacos , Colon/metabolismo , Colon/microbiología , Neoplasias del Colon/metabolismo , Neoplasias del Colon/microbiología , Neoplasias del Colon/patología , Microbioma Gastrointestinal/efectos de los fármacos , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/metabolismo , Mucosa Intestinal/microbiología , Ratones Endogámicos A , Proteínas de Neoplasias/genética , Proteínas de Neoplasias/metabolismo , Lesiones Precancerosas/metabolismo , Lesiones Precancerosas/microbiología , Lesiones Precancerosas/patología , Ratas Endogámicas F344 , Almidón Resistente , Almidón/análogos & derivados , Almidón/metabolismo , Ácidos Esteáricos/metabolismo , Ácidos Esteáricos/uso terapéutico , Anhídridos Succínicos/metabolismo , Anhídridos Succínicos/uso terapéutico , Carga Tumoral/efectos de los fármacos , Vía de Señalización Wnt/efectos de los fármacos
3.
Farmakol Toksikol ; 52(5): 41-3, 1989.
Artículo en Ruso | MEDLINE | ID: mdl-2599076

RESUMEN

Pirrolidone-2, gamma-butyrolacton, succinic anhydride were found to possess pronounced antihypoxic activity that manifested itself in their ability to decrease the level of lactic acid accumulated during hypoxia. Pirrolidone-2 and succinic anhydride increase succinic dehydrogenase activity in vitro. At intraperitoneal administration the above mentioned compounds lead to lactate dehydrogenase activity inhibition under normal conditions while during circulatory hypoxia they stimulate lactate dehydrogenase reaction promoting the maintenance of energy balance of the cerebral tissue at the appropriate level.


Asunto(s)
Hipoxia Encefálica/tratamiento farmacológico , Ácido gamma-Aminobutírico/análogos & derivados , 4-Butirolactona/uso terapéutico , Animales , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Evaluación Preclínica de Medicamentos , Hipoxia Encefálica/metabolismo , L-Lactato Deshidrogenasa/metabolismo , Lactatos/metabolismo , Ácido Láctico , Pirrolidinonas/uso terapéutico , Piruvatos/metabolismo , Ácido Pirúvico , Ratas , Succinato Deshidrogenasa/metabolismo , Anhídridos Succínicos/uso terapéutico , Ácido gamma-Aminobutírico/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...